Candida vulvovaginitis classification: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
| (10 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Candida vulvovaginitis}} | ||
{{CMG}}; {{AE}}{{DN}} | {{CMG}}; {{AE}}{{DN}}, {{AKI}} | ||
==Overview== | ==Overview== | ||
[[Candida]] [[vulvovaginitis]] can be classified based on the duration, as well as the strain of [[Candida]] causing the infection. | |||
==Classification== | ==Classification== | ||
[[Candida]] [[vulvovaginitis]] can be | [[Candida]] [[vulvovaginitis]] can be classified based on the duration of the infection and based on the [[strain]] of [[Candida]] causing the infection. | ||
*'' | ===Duration=== | ||
*'' | [[Candida]] [[vulvovaginitis]] can be divided based on the duration and number of episodes of the infection into:<ref name="pmid16990387">{{cite journal |vauthors=Eckert LO |title=Clinical practice. Acute vulvovaginitis |journal=N. Engl. J. Med. |volume=355 |issue=12 |pages=1244–52 |year=2006 |pmid=16990387 |doi=10.1056/NEJMcp053720 |url=}}</ref><ref name="pmid9500475">{{cite journal |vauthors=Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR |title=Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations |journal=Am. J. Obstet. Gynecol. |volume=178 |issue=2 |pages=203–11 |year=1998 |pmid=9500475 |doi= |url=}}</ref><ref name="pmid17560449">{{cite journal |vauthors=Sobel JD |title=Vulvovaginal candidosis |journal=Lancet |volume=369 |issue=9577 |pages=1961–71 |year=2007 |pmid=17560449 |doi=10.1016/S0140-6736(07)60917-9 |url=}}</ref><ref name="pmid7995997">{{cite journal |vauthors=Vazquez JA, Sobel JD, Demitriou R, Vaishampayan J, Lynch M, Zervos MJ |title=Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis |journal=J. Infect. Dis. |volume=170 |issue=6 |pages=1566–9 |year=1994 |pmid=7995997 |doi= |url=}}</ref> | ||
*'' | *'''Acute, uncomplicated''': these are usually sporadic cases of [[Candida]] [[vulvovaginitis]], which respond to [[topical]] [[antifungal therapy]] and have a high cure rate. | ||
*'''Acute, complicated''': symptoms are more severe than uncomplicated infections and typically require a combination of oral and topical [[anti-fungal]] treatment. | |||
* | *'''Recurrent Vulvovaginal Candidiasis (RVVC)''': defined as 4 or more episodes of [[Candida]] [[vulvovaginitis]] per year, usually caused by the same [[strain]] of [[Candida]]. Treatment also requires a combination of oral and [[topical]] [[antifungal agents]]. | ||
*According to 2015, Treatment of STD guidelines - Candida vulvovaginitis can be classified into uncomplicated and complicated based on the following features:<ref name="pmid26602614">{{cite journal| author=Workowski KA| title=Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. | journal=Clin Infect Dis | year= 2015 | volume= 61 Suppl 8 | issue= | pages= S759-62 | pmid=26602614 | doi=10.1093/cid/civ771 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26602614 }}</ref> | |||
{| class="wikitable" | |||
!Uncomplicated Candida Vulvovaginitis | |||
!Complicated Candida Vulvovaginitis | |||
|- | |||
| | |||
*Sporadic or infrequent VVC | |||
*Mild-to-moderate VVC | |||
*Likely to be [[Candida albicans]] | |||
*Non-immunocompromised women | |||
| | |||
*Recurrent VVC | |||
*Severe VVC | |||
*Non-albicans candidiasis | |||
*Women with [[diabetes]], [[immunocompromised]] conditions such as [[HIV]] infection), [[debilitation]] | |||
*[[immunosuppressive|Immunosuppressive therapy]]: [[corticosteroids]] use | |||
|} | |||
==References== | ==References== | ||
| Line 16: | Line 37: | ||
{{WH}}{{WS}} | {{WH}}{{WS}} | ||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Gynecology]] | |||
[[Category:Obstetrics]] | |||
Latest revision as of 20:46, 29 July 2020
|
Candida vulvovaginitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Candida vulvovaginitis classification On the Web |
|
American Roentgen Ray Society Images of Candida vulvovaginitis classification |
|
Risk calculators and risk factors for Candida vulvovaginitis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2], Aravind Kuchkuntla, M.B.B.S[3]
Overview
Candida vulvovaginitis can be classified based on the duration, as well as the strain of Candida causing the infection.
Classification
Candida vulvovaginitis can be classified based on the duration of the infection and based on the strain of Candida causing the infection.
Duration
Candida vulvovaginitis can be divided based on the duration and number of episodes of the infection into:[1][2][3][4]
- Acute, uncomplicated: these are usually sporadic cases of Candida vulvovaginitis, which respond to topical antifungal therapy and have a high cure rate.
- Acute, complicated: symptoms are more severe than uncomplicated infections and typically require a combination of oral and topical anti-fungal treatment.
- Recurrent Vulvovaginal Candidiasis (RVVC): defined as 4 or more episodes of Candida vulvovaginitis per year, usually caused by the same strain of Candida. Treatment also requires a combination of oral and topical antifungal agents.
- According to 2015, Treatment of STD guidelines - Candida vulvovaginitis can be classified into uncomplicated and complicated based on the following features:[5]
| Uncomplicated Candida Vulvovaginitis | Complicated Candida Vulvovaginitis |
|---|---|
|
|
References
- ↑ Eckert LO (2006). "Clinical practice. Acute vulvovaginitis". N. Engl. J. Med. 355 (12): 1244–52. doi:10.1056/NEJMcp053720. PMID 16990387.
- ↑ Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR (1998). "Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations". Am. J. Obstet. Gynecol. 178 (2): 203–11. PMID 9500475.
- ↑ Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.
- ↑ Vazquez JA, Sobel JD, Demitriou R, Vaishampayan J, Lynch M, Zervos MJ (1994). "Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis". J. Infect. Dis. 170 (6): 1566–9. PMID 7995997.
- ↑ Workowski KA (2015). "Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines". Clin Infect Dis. 61 Suppl 8: S759–62. doi:10.1093/cid/civ771. PMID 26602614.